Table 1.

Mean change in mRSS in the dcSSc subset in the SLS-1 and SLS-2

	SLS-2 pooled group		SLS-1 CYC group		SLS-2 pooled and SLS-1 CYC groups		SLS-1 Placebo group

	N		N		N		N

Baseline	83	20.8	49	21.6	132	21.1	46	20.4
6 month	69	−2.4^†	45	−2.7^†	114	−2.6^†	43	−2.6^†
12 month	66	−5.5^†	43	−5.3^†	109	−5.4*^†	37	−1.7*

^†P<0.05 for for mRSS at follow up vs. baseline within each group. *P<0.05 for SLS-II pooled and SLS-I CYC groups compared to SLS-1 Placebo group.